Fundamental Analysis of BlackRock Health Sci TR - Growth / Value Index
BME - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 18.65 | 27.97 | 233.04 % | |
| Price to Book | 0.942 | 0.952 | 2.67 % | 0.952 |
| Price to Sales | 14.36 | 27.43 | 228.01 % | |
| Enterprise Value to EBITDA Multiple | 19.29 | 27.97 | 233.05 % |
BME - Profitability Highlights
Profitability Analysis
Tsr Profitability Index - Good Score of 79.38
Piotroski F Score - Good Value of 7.0
Gives Dividend Yield of 6.36 %
Net profit has jumped from negative to positive
Company Earning excess return
During the past twelve months, the company has given a strong Net Margin of 77.00%
All key Trailing Twelve Months Margin growing by 15 %
Low Earning Yield of 5.41 %
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 5.05 | 3.40 | 177.17 % | 1.48 |
| Return On Asset | 4.98 | 3.36 | 176.89 % | 1.46 |
| Net Profit Margin | 77.00 | 98.07 | -3.78 % | 47.60 |
| Operating Profit Margin | 53.93 | 98.11 | -3.74 % | 47.62 |
| EBITDA Margin | 74.45 | 98.07 | -3.78 % | 47.62 |
Highlights
| Market Cap | 559851 K |
| Enterprise Value | 559911 K |
| Price/Book TTM | 0.942 |
| Outstanding Share | 13944.00 K |
| Float/ Outstanding Share | 0% |
| Dividend Yield | 6.37 % |
Share Holding
Guru Numbers
| Price/Graham No | 0.888 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 7.00 |
| Altman Z Score | 42.70 |
| Sloan Ratio | -0.0201 |
| Peter Lynch Fair Value | 0 |
BME - Growth Highlights
Growth Analysis
Quarterly sales in last 5 years is trending up
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 38992.51 K | 178.59 % | 829.43 % |
| Gross Profit | 32971.54 K | 211.18 % | 676.06 % |
| EBITDA | 29030.32 K | 175.62 % | 121.23 % |
| Net Profit | 30025.53 K | 175.62 % | 100.00 % |
| EPS | 2.15 | 175.17 % | NA |
BME - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 95.00
Altman Z Score of 42.32 suggests good Stability
Cash ratio of 517.38
Company financial liquidity has improved
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.0001 | 2020.91 % | 0.0001 |
| Cash Ratio | 517.38 | 405.36 % | |
| Quick Ratio | 0 | 0 % | 26.71 |
| Shareholders Equity | 98.66 | -0.362 % | |
| Debt to EBITDA | 0.0030 | 2848.38 % |
Historical Valuation Ratios of BlackRock Health Sci TR
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of BlackRock Health Sci TR
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of BlackRock Health Sci TR
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of BlackRock Health Sci TR
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)